Restructure

Pharma

Takeda, GLP-1 generics, Gilead—Fierce Pharma Asia

Takeda aims to save $1.3 billion in a restructuring. Generic semaglutide launches started in India. Gilead offered to buy a Chinese "NewCo." And more.

Angus Liu Mar 27, 2026 8:38am

Takeda targets $1.3B in savings with new efficiency drive

Mar 25, 2026 10:44am

Large pharma companies reduced head counts by over 22K in 2025

Mar 23, 2026 4:25pm

Sandoz to break its biosimilars business out from generics

Mar 10, 2026 4:01pm

cost cutting restructuring savings reduce spend

InflaRx charts layoffs, cost cuts to lift lead asset's prospects

Jan 8, 2026 11:03am

Geron plots deep layoffs in bid to curb operating costs

Dec 11, 2025 1:50pm